UAB Pharma Nord Lithuania Finance - revenue, profit
EBITDA margin (%)
Enjoy unlimited use
with Freemium unlimitedEBIT margin (%)
Enjoy unlimited use
with Freemium unlimited| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2023 |
|---|
| 352,698 |
| 80,341 |
| 28,184 |
| 22,308 |
| 5,082 |
| 9.02 |
| 6.32 |
| 39,810 |
| 91,754 |
| 8,081 |
| 122,858 |
| 2024 |
|---|
| 550,179 |
| 110,036 |
| 25,920 |
| 22,751 |
| 4,550 |
| 5.73 |
| 4.14 |
| 26,561 |
| 536,177 |
| 6,716 |
| 510,767 |
| 2025 |
|---|
| 647,018 |
| 142,202 |
| 34,831 |
| 28,675 |
| 6,302 |
| 7.30 |
| 4.43 |
| 32,236 |
| 237,641 |
| 5,351 |
| 258,165 |
Enjoy unlimited use
with Freemium unlimited| 2025 |
|---|
| 647,018 |
| 142,202 |
| 34,831 |
| 28,675 |
| 6,302 |
| 7.30 |
| 4.43 |
| 32,236 |
| 237,641 |
| 5,351 |
| 258,165 |
Enjoy unlimited use
with Freemium unlimitedTurnover (€)
2025
Turnover (€)
647,018 €18 % *
Sales per employee (€)
142,202 €29 % *
Profit before tax (€)
34,831 €34 % *
Net Profit (€)
28,675 €26 % *
Profit per employee (€)
6,302 €39 % *
Total profitability (%)
7.30 %27.40 % *
Net profitability (%)
4.43 %7.00 % *
Equity (€)
32,236 €21 % *
Amounts Payable And Liabilities (€)
237,641 €-56 % *
Non-current Assets (€)
5,351 €-20 % *
CurrentAssets (€)
258,165 €-49 % *
